177.69M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments.

Similar securities

Based on sector and market capitalization

Report issue